drugset / Trial / NCT06423820

Preoperative Ondansetron Lozenge for Prevention of Postoperative Nausea and Vomiting in Pediatrics Undergoing Squint Surgeries

NCT06423820

Completed 80 enrolled Tanta University
RandomizedParallel-groupOpen-labelPrevention

Summary

The aim of this study is to evaluate the role of ondansetron lozenge on prevention of postoperative nausea and vomiting (PONV) in pediatrics undergoing squint surgeries.

Timeline

Start
2024-05-21
Primary completion
2025-01-23
Completion
2025-01-23

Drugs

EvaluationDrugModalityDoseRoute
Subject Ondansetron Other / unclassified 4 mg

Indications